We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Breaking News & Company Info

Get access to Genentech information and resources for stories in development. Find recent and archived press releases.